BioSure

BioSure is a UK-based startup that is focused on providing rapid in-vitro diagnostic testing solutions. The company's slogan "BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream" encapsulates their mission to make diagnostic testing more accessible. Founded in 2013, BioSure is making strides in the Health Care and Manufacturing industries. The company is committed to expanding the use of rapid testing in healthcare and self-testing. Their goal is to change how disease diagnosis and drug detection are conducted in various settings, including personal, clinical, law enforcement, and commercial environments. Their dedication to making this technology accessible to everyone is evident in their efforts to make it cost-effective, straightforward, speedy, and accurate. In terms of support, BioSure received a Non-Equity Assistance investment from Pitch@Palace on November 7, 2018. This represents a vote of confidence from investors in the potential of BioSure's innovative approach to diagnostic testing. As the company continues to make advancements in the diagnostic testing space, it will be interesting to see how they utilize this support to further their impact in the healthcare and manufacturing industries.